ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection ...

Details on the presentation can be found below. A copy of the Company's poster presentation will be available under the Scientific Presentations tab of the Tonix website at following the conference.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250605967851/en/ The articles, information, and content displayed on this webpage ...

Tonix is a fully-integrated biotech company focused on transforming therapies for pain management and vaccines for public health challenges. Tonix’s development portfolio is focused on central nervous ...

Abstracts related to the EACR meeting will be published online following the presentation. For more information, please visit the EACR 2025 website. Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a ...

The conference will mainly have invited speakers. However, there will be a speed presentation and poster session since we believe there are many interesting projects dealing with invasive alien ...

Abstracts related to the EACR meeting will be published online following the presentation. For more information, please visit the EACR 2025 website. Purple Biotech Ltd. (NASDAQ/TASE: PPBT ...

A copy of the presentation materials will be made available on the “Publications and Posters” section of the Company’s website at https://www.contexttherapeutics.com. About CTIM-76CTIM-76 ...

UCSF Presentations (all times CDT): June 1 ... from 4:30 p.m. to 4:42 p.m. Chien will also present the poster “Serum estradiol (sE2) levels in premenopausal (PreM) women receiving neoadjuvant ovarian ...

All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday in the last week of the fall and winter semesters ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

today announces that it will have a poster presentation on 303 Study, the investigator-initiated study supported by Merck (known as MSD outside of the United States and Canada) and BeyondSpring in ...